Latest Research in Clinical Leukemia Therapeutics
27 research papers · 2026 median publication year
Top Research Topics in Clinical Leukemia Therapeutics
- Acute Myeloid Leukemia Research — 22 papers
- Neutropenia and Cancer Infections — 1 papers
- Epigenetics and DNA Methylation — 1 papers
- Wittgensteinian philosophy and applications — 1 papers
- Acute Lymphoblastic Leukemia research — 1 papers
- Nuclear Engineering Thermal-Hydraulics — 1 papers
Highest-Cited Papers
- Prolonged treatment-free remission after venetoclax in combination with a hypomethylating agent in acute myeloid leukemia with inv(16)
- Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation
- Defining a Therapeutic Window for Venetoclax in Post‐Transplant Maintenance Therapy for High‐Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
- DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy
- Optimizing venetoclax duration with hypomethylating agents for newly diagnosed acute myeloid leukemia: impact on response and survival
- Association between venetoclax concentration and febrile neutropenia in acute leukemia: a retrospective analysis
- High-throughput UHPLC-MS/MS Assay for the Quantification of Venetoclax in Patients with Acute Myeloid Leukemia and Assessment of Clinical Application: A Short Communication
- Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine
- Dose‐Adjusted Treatment With 7‐Day Venetoclax Plus Azacitidine or Decitabine in Patients With Acute Myeloid Leukaemia
- Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study
- Essays on Logic, Ethics, and Universal Grammar
- OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML
- Successful treatment of B-cell acute lymphoblastic leukemia with SET-NUP214 rearrangement using venetoclax: A first case report and literature review
- Effects of azacitidine combined with venetoclax on inflammatory markers and overall response rate in elderly patients with newly diagnosed acute myeloid leukemia
- Advanced Control Method for Forced-Natural Cycle Switching Process in Small Pressurized Water Reactors
- Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting
- Informing the debate: hypomethylating agents/venetoclax or intensive chemotherapy to treat acute myeloid leukemias
- A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia
- Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia"
- Real-world clinical outcomes of newly diagnosed AML unfit for intensive chemotherapy treated with venetoclax and azacitidine: does it depend on the number of days of venetoclax administration?
Sub-Regions
- Acute Myeloid Leukemia Research — 18 papers
- Wittgensteinian philosophy and applications — 4 papers
- Acute Myeloid Leukemia Research — 2 papers
- Acute Myeloid Leukemia Research — 2 papers
- Acute Myeloid Leukemia Research — 2 papers
- Epigenetics and DNA Methylation — 1 papers